Opportunities for Medication Development in Obesity.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 49, doi. 10.1002/1098-2299(200010)51:2<49::AID-DDR1>3.0.CO;2-0
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2000 AND VI 51 AND IP 2
Results: 7
1
2
NPY-Ergic agents for the treatment of obesity.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 94, doi. 10.1002/1098-2299(200010)51:2<94::AID-DDR5>3.0.CO;2-Z
- By:
- Publication type:
- Article
3
Development of β<sub>3</sub>-adrenoceptor agonists as antiobesity and antidiabetes drugs in humans: Current status and future prospects.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 80, doi. 10.1002/1098-2299(200010)51:2<80::AID-DDR4>3.0.CO;2-E
- By:
- Publication type:
- Article
4
Leptin and the treatment of obesity.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 66, doi. 10.1002/1098-2299(200010)51:2<66::AID-DDR3>3.0.CO;2-1
- By:
- Publication type:
- Article
5
Cocaine- and amphetamine-regulated transcript (CART) and food intake: Behavior in search of anatomy.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 124, doi. 10.1002/1098-2299(200010)51:2<124::AID-DDR7>3.0.CO;2-P
- By:
- Publication type:
- Article
6
Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 52, doi. 10.1002/1098-2299(200010)51:2<52::AID-DDR2>3.0.CO;2-H
- By:
- Publication type:
- Article
7
Uncoupling proteins 2 and 3 and their potential role in human obesity.
- Published in:
- Drug Development Research, 2000, v. 51, n. 2, p. 112, doi. 10.1002/1098-2299(200010)51:2<112::AID-DDR6>3.0.CO;2-Z
- By:
- Publication type:
- Article